.jpg)
The U.S. Food and Drug Administration sent a warning letter in May 2025 to Supreme Rejuvenation, LLC, a Houston company that sold exosome products online. According to the letter, the company sold three products described as human umbilical cord stem cell derived exosomes, including two gels, for allogeneic use.
The Lyon Firm is investigating misleading claims and deceptive marketing at stem cell clinics nationwide, and federal enforcement actions like this one show how closely regulators watch these claims.
The FDA’s Center for Biologics Evaluation and Research reviewed the company’s website and Instagram page. The agency says the stem cell-derived exosome products qualify as unapproved new drugs and unlicensed biological products. It also says no investigational new drug application or biologics license covered them.
The company’s website described the products as intended for research and investigational purposes. The FDA stated that this disclaimer did not change its position.
The FDA cited website and social media language it says suggested the products could treat disease. Examples include references to wound care, traumatic brain injury, joint repair, arthritis, fibromyalgia and diabetes.
Under federal law, a product marketed to treat or prevent disease generally counts as a drug. A company needs FDA approval or licensure before selling it across state lines.
The letter also pointed to the FDA’s public safety notification on exosome products, which followed reports of serious adverse events in patients. The FDA gave the company 15 working days to respond.
The FDA has stated it has approved no exosome products. Patients who paid for exosome injections, infusions or gels from any stem cell clinic after hearing promises of healing may have legal options, depending on the facts of their case.
The Lyon Firm represents consumers nationwide in deceptive medical marketing cases. Our attorneys investigate claims involving unapproved stem cell and exosome treatments, and we explain your options in a free, confidential consultation. Call (513) 381-2333 or contact us online to discuss what happened.
Taking the first step doesn’t have to be complicated. In just a few minutes, you can share the basics of your case, and our team will guide you from there: